Study to Evaluate Ibudilast and TMZ Combo Treatment in Newly Diagnosed and Recurrent Glioblastoma

NCT03782415 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

64

Enrollment

INDUSTRY

Sponsor class

Conditions

Glioblastoma
Recurrent Glioblastoma
GBM
Newly Diagnosed Glioblastoma

Interventions

DRUG: MN-166
DRUG: Temozolomide

Sponsor

MediciNova